person · Reporting owner
Kurzius Lawrence Erik
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COOPER COMPANIES, INC.COO · Entity 3395 | Director | September 16, 2026 | September 17, 2026 |
| Elanco Animal Health IncELAN · Entity 3457 | Director | August 20, 2026 | August 21, 2026 |
| Lamb Weston Holdings, Inc.LW · Entity 3684 | Director | October 08, 2026 | October 09, 2026 |
| MCCORMICK & CO INCMKC · Entity 1416 | 10% owner | August 10, 2026 | August 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COOPER COMPANIES, INC.
Report date September 16, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,099 |
Reported balance
After 2026-09-16 transaction · row 1
1 source rowRow 1 · 2026-09-16 · Purchase · Acquired 10,000 · Balance 31,099 |
Elanco Animal Health Inc
Report date August 20, 2026 · Filed August 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 188,647 |
Reported balance
After 2026-08-20 transaction · row 1
1 source rowRow 1 · 2026-08-20 · Purchase · Acquired 40,000 · Balance 188,647 F1: Reflects the weighted average price of 40,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 20, 2026 with purchase prices ranging from $23.385 to $23.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the weighted average price of 40,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 20, 2026 with purchase prices ranging from $23.385 to $23.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Lamb Weston Holdings, Inc.
Report date October 08, 2026 · Filed October 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,054 |
Reported balance
After 2026-10-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-08 · Grant · Acquired 5,458 · Balance 11,054 F1: Represents restricted stock units ("RSUs") that vest on the earlier of (1) the first anniversary of the date of grant and (2) the date of the next annual meeting of Lamb Weston Holdings, Inc.'s ("Lamb Weston") stockholders that is at least 50 weeks after September 16, 2026, or earlier upon certain events. Each RSU represents a contingent right to receive one share of Lamb Weston common stock upon settlement. F2: Includes 135 additional shares acquired since the date of the reporting person's last report through a dividend reinvestment feature. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") that vest on the earlier of (1) the first anniversary of the date of grant and (2) the date of the next annual meeting of Lamb Weston Holdings, Inc.'s ("Lamb Weston") stockholders that is at least 50 weeks after September 16, 2026, or earlier upon certain events. Each RSU represents a contingent right to receive one share of Lamb Weston common stock upon settlement.
F2: Includes 135 additional shares acquired since the date of the reporting person's last report through a dividend reinvestment feature.
MCCORMICK & CO INC
Report date August 10, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock - VotingSEC Table I · non-derivative | Direct | 296,992 |
Ending reported balance
After 2026-08-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-10 · Exercise / conversion · Acquired 205,538 · Balance 502,530 Row 2 · 2026-08-10 · Sale · Disposed 205,538 · Balance 296,992 |
| Options - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $49.03 · Expires 2027-03-29 | Direct | 0 |
Reported balance
After 2026-08-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-10 · Exercise / conversion · Disposed 205,538 · Balance 0 F1: Option exercised; no purchase price required. |
Filing footnotes · ownership attribution and instrument terms
F1: Option exercised; no purchase price required.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 03, 2025 Filed Feb 4, 2025 20:15 UTC | MCCORMICK & CO INC MKC · Entity 1416 | SaleCommon Stock - Voting | 50,000 | $76.81 | $3,840,320.00 |
DisclosureSEC source: 0001062993-25-001602 · form4.xml · nonDerivative · entry 2 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,895 Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 20:15 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionCommon Stock - Voting | 50,000 | $49.96 | $2,498,000.00 |
DisclosureSEC source: 0001062993-25-001602 · form4.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 326,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 16:42 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GrantCommon Stock - Voting | 77,637 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-001223 · form4.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,895 F3 · shares: Shares awarded pursuant to McCormick's Long-Term Incentive Program (LTIP) for the three (3) year performance cycle beginning on December 1, 2021 and ending on November 30, 2024. Read SEC document |
| January 13, 2025 Filed Jan 29, 2025 16:42 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 198.514 | $71.24 | $14,142.14 |
DisclosureSEC source: 0001062993-25-001223 · form4.xml · derivative · entry 8 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Non-Qualified Retirement Savings Plan Disclosed balance after: 31,625.995 Underlying: Common Stock - Voting · 198.514 shares Expires not disclosed F2 · derivative.exercise_price: Dividend Reinvestment. F2 · derivative.exercise_date: Dividend Reinvestment. F2 · derivative.expiration_date: Dividend Reinvestment. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:32 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 4,954.583 | $12.11 | $60,000.00 |
DisclosureSEC source: 0001415889-25-000468 · form4-01032025_090111.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,567.1413 Underlying: Common Stock · 4,954.583 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.11 on December 31, 2024. F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.11 on December 31, 2024. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 21:28 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GrantRestricted Stock Units · Derivative | 5,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-019946 · form4.xml · derivative · entry 8 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,203 Underlying: Common Stock - Voting · 5,203 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in thirds over a three-year period beginning December 2, 2025, December 2, 2026 and December 2, 2027. F4 · derivative.expiration_date: The Restricted Stock Units vest in thirds over a three-year period beginning December 2, 2025, December 2, 2026 and December 2, 2027. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:18 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 18,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-028163 · form4-12032024_101243.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,459 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| October 21, 2024 Filed Dec 3, 2024 21:28 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 168.91 | $78.06 | $13,185.11 |
DisclosureSEC source: 0001062993-24-019946 · form4.xml · derivative · entry 7 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Non-Qualified Retirement Savings Plan Disclosed balance after: 31,428.2 Underlying: Common Stock - Voting · 168.91 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock - Voting. Shares of Phantom Stock are payable in shares of Common Stock - Voting in accordance with the terms of the Non-Qualified Retirement Savings Plan. F2 · derivative.exercise_date: Each share of phantom stock represents the right to receive one share of Common Stock - Voting. Shares of Phantom Stock are payable in shares of Common Stock - Voting in accordance with the terms of the Non-Qualified Retirement Savings Plan. F2 · derivative.expiration_date: Each share of phantom stock represents the right to receive one share of Common Stock - Voting. Shares of Phantom Stock are payable in shares of Common Stock - Voting in accordance with the terms of the Non-Qualified Retirement Savings Plan. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:38 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 4,084.4112 | $14.69 | $60,000.00 |
DisclosureSEC source: 0001415889-24-024422 · form4-10022024_081007.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,612.5583 Underlying: Common Stock · 4,084.4112 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $14.69 on September 30, 2024. F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $14.69 on September 30, 2024. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| September 11, 2024 Filed Sep 11, 2024 20:35 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GiftCommon Stock - Voting | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016482 · form4.xml · nonDerivative · entry 4 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By 2022 GRAT F Disclosed balance after: 0 F2 · price: Shares gifted; No purchase price required. F1 · balance_after: Upon termination of the Reporting Person's 2022 grantor retained annuity trusts, the Reporting Person gifted 2 shares of Common Stock - Voting and the remaining 11,806 shares of Common Stock - Voting were returned to the Reporting Person's direct holdings. Read SEC document |
| September 11, 2024 Filed Sep 11, 2024 20:35 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GiftCommon Stock - Voting | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016482 · form4.xml · nonDerivative · entry 3 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By 2022 GRAT E Disclosed balance after: 0 F2 · price: Shares gifted; No purchase price required. F1 · balance_after: Upon termination of the Reporting Person's 2022 grantor retained annuity trusts, the Reporting Person gifted 2 shares of Common Stock - Voting and the remaining 11,806 shares of Common Stock - Voting were returned to the Reporting Person's direct holdings. Read SEC document |
| July 22, 2024 Filed Sep 11, 2024 20:35 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 177.78 | $73.43 | $13,054.39 |
DisclosureSEC source: 0001062993-24-016482 · form4.xml · derivative · entry 7 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Non-Qualified Retirement Savings Plan Disclosed balance after: 31,259.29 Underlying: Common Stock - Voting · 177.78 shares Expires not disclosed F3 · derivative.exercise_price: Dividend Reinvestment F3 · derivative.exercise_date: Dividend Reinvestment F3 · derivative.expiration_date: Dividend Reinvestment F4 · balance_after: Due to an administrative error, the shares held by the Reporting Person in the Registrant's NQRSP were not included in the Reporting Person's Form 4s filed on July 12, 2024 and July 17, 2024, respectively. Read SEC document |
| July 17, 2024 Filed Jul 17, 2024 17:27 UTC | MCCORMICK & CO INC MKC · Entity 1416 | SaleCommon Stock - Non Voting | 25,000 | $75.00 | $1,875,000.00 |
DisclosureSEC source: 0001062993-24-013872 · form4.xml · nonDerivative · entry 7 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · IRA Disclosed balance after: 0 Read SEC document |
| July 10, 2024 Filed Jul 12, 2024 12:02 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherCommon Stock - Non Voting | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-24-013666 · form4.xml · nonDerivative · entry 8 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · IRA Disclosed balance after: 25,000 F1 · price: Exchange of shares of Common Stock - Voting for shares of Common Stock - Non-Voting on a one for one basis. Read SEC document |
| July 10, 2024 Filed Jul 12, 2024 12:02 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherCommon Stock - Voting | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-24-013666 · form4.xml · nonDerivative · entry 2 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · IRA Disclosed balance after: 0 F1 · price: Exchange of shares of Common Stock - Voting for shares of Common Stock - Non-Voting on a one for one basis. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:06 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 2,673.0028 | $14.43 | $38,571.43 |
DisclosureSEC source: 0001415889-24-018857 · form4-07022024_080755.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,528.1471 Underlying: Common Stock · 2,673.0028 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $14.43 on June 28, 2024. F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $14.43 on June 28, 2024. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| May 21, 2024 Filed May 22, 2024 16:02 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionOptions - Right to Buy · Derivative | 80,000 | Not disclosed Strike: $38.15 | Not disclosed |
DisclosureSEC source: 0001062993-24-010918 · form4.xml · derivative · entry 10 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock - Voting · 80,000 shares Expires 2025-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Options Exercised. Read SEC document |
| May 21, 2024 Filed May 22, 2024 16:02 UTC | MCCORMICK & CO INC MKC · Entity 1416 | SaleCommon Stock - Voting | 80,000 | $73.75 | $5,900,024.00 |
DisclosureSEC source: 0001062993-24-010918 · form4.xml · nonDerivative · entry 2 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,258 Read SEC document |
| May 21, 2024 Filed May 22, 2024 16:02 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionCommon Stock - Voting | 80,000 | $38.15 | $3,051,600.00 |
DisclosureSEC source: 0001062993-24-010918 · form4.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 279,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 22, 2024 Filed May 22, 2024 16:02 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 173.801 | $74.69 | $12,981.20 |
DisclosureSEC source: 0001062993-24-010918 · form4.xml · derivative · entry 9 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Non Qualified Retirement Plan Disclosed balance after: 31,081.51 Underlying: Common Stock - Voting · 173.801 shares Expires not disclosed F1 · derivative.exercise_price: Dividend Reinvestment F1 · derivative.exercise_date: Dividend Reinvestment F1 · derivative.expiration_date: Dividend Reinvestment Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:52 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantRestricted Stock Units · Derivative | 2,721 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-003261 · primarydocument.xml · derivative · entry 3 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,721 Underlying: Common Stock · 2,721 shares Expires not disclosed F2 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:52 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionRestricted Stock Units · Derivative | 1,056 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-003261 · primarydocument.xml · derivative · entry 2 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,056 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Adjusted to reflect Issuer's 4-for-1 stock split effected on February. 16, 2024. F2 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:52 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionCommon Stock | 1,056 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-003261 · primarydocument.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Adjusted to reflect Issuer's 4-for-1 stock split effected on February. 16, 2024. Read SEC document |
| March 29, 2024 Filed Apr 2, 2024 20:15 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 1,689.1892 | $16.28 | $27,500.00 |
DisclosureSEC source: 0001415889-24-009756 · form4-04022024_080425.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,855.1443 Underlying: Common Stock · 1,689.1892 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $16.28 on March 29, 2024. F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $16.28 on March 29, 2024. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 15:51 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Tax withholdingCommon Stock - Voting | 25,744 | $65.00 | $1,673,231.28 |
DisclosureSEC source: 0001062993-24-003586 · form4.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,258 F1 · shares: Shares withheld for taxes on the shares previously reported on 1/24/2024 for McCormick's Long-Term Incentive Plan. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 20:34 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GrantCommon Stock - Voting | 65,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-001236 · form4.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,002 F1 · shares: Shares awarded pursuant to McCormick's Long-Term Incentive Program (LTIP) for the three (3) year performance cycle beginning on December 1, 2020 and ending on November 30, 2023. Read SEC document |
| January 08, 2024 Filed Jan 24, 2024 20:34 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 191.916 | $67.22 | $12,900.59 |
DisclosureSEC source: 0001062993-24-001236 · form4.xml · derivative · entry 8 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Non Qualified Retirement Plan Disclosed balance after: 30,907.709 Underlying: Common Stock - Voting · 191.916 shares Expires not disclosed F2 · derivative.exercise_price: Dividend Reinvestment. F2 · derivative.exercise_date: Dividend Reinvestment. F2 · derivative.expiration_date: Dividend Reinvestment. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:48 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 1,845.6376 | $14.90 | $27,500.00 |
DisclosureSEC source: 0001415889-24-000321 · form4-01032024_090140.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,165.9551 Underlying: Common Stock · 1,845.6376 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $14.90 on December 29, 2023. F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $14.90 on December 29, 2023. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:36 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GrantOptions - Right to Buy · Derivative | 313,532 | $0.00 Strike: $65.99 | $0.00 |
DisclosureSEC source: 0001062993-23-021957 · form4.xml · derivative · entry 10 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 313,532 Underlying: Common Stock - Voting · 313,532 shares Expires not disclosed F2 · derivative.exercise_date: The option grant becomes exercisable in thirds of each of the first three (3) grant anniversaries. F2 · derivative.expiration_date: The option grant becomes exercisable in thirds of each of the first three (3) grant anniversaries. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 20:02 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantRestricted Stock Units · Derivative | 264 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-008089 · primarydocument.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 264 Underlying: Common Stock · 264 shares Expires 2024-04-01 F1 · price: There is no exercise price associated with the grant of Restricted Stock Units. Read SEC document |
| December 01, 2023 Filed Dec 8, 2023 21:52 UTC Amendment | MCCORMICK & CO INC MKC · Entity 1416 | GrantOptions - Right to Buy · Derivative | 313,532 | $0.00 Strike: $65.99 | $0.00 |
DisclosureSEC source: 0001062993-23-022232 · form4a.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 313,532 Underlying: Common Stock - Voting · 313,532 shares Expires not disclosed F1 · derivative.exercise_date: This amendment is being filed to correct the (i) vesting schedule of the option grant, which option will vest in equal increments on March 27 of 2024, 2025 and 2026; and (ii) the relationship of the Reporting Person to the Issuer. F1 · derivative.expiration_date: This amendment is being filed to correct the (i) vesting schedule of the option grant, which option will vest in equal increments on March 27 of 2024, 2025 and 2026; and (ii) the relationship of the Reporting Person to the Issuer. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 22:36 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 20,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-015787 · form4-12042023_101255.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,290 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| October 24, 2023 Filed Dec 5, 2023 22:36 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 191.086 | $62.30 | $11,904.66 |
DisclosureSEC source: 0001062993-23-021957 · form4.xml · derivative · entry 9 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Non Qualified Retirement Plan Disclosed balance after: 30,715.783 Underlying: Common Stock - Voting · 191.086 shares Expires not disclosed F1 · derivative.exercise_price: Dividend Reinvestment F1 · derivative.exercise_date: Dividend Reinvestment F1 · derivative.expiration_date: Dividend Reinvestment Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 20:38 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 2,446.6192 | $11.24 | $27,500.00 |
DisclosureSEC source: 0001415889-23-013884 · form4-10032023_081051.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,320.3175 Underlying: Common Stock · 2,446.6192 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $11.24 on September 29, 2023. F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $11.24 on September 29, 2023. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| July 24, 2023 Filed Dec 5, 2023 22:36 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 133.518 | $88.77 | $11,852.39 |
DisclosureSEC source: 0001062993-23-021957 · form4.xml · derivative · entry 8 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Non Qualified Retirement Savings Plan Disclosed balance after: 30,524.697 Underlying: Common Stock - Voting · 133.518 shares Expires not disclosed F1 · derivative.exercise_price: Dividend Reinvestment F1 · derivative.exercise_date: Dividend Reinvestment F1 · derivative.expiration_date: Dividend Reinvestment Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 21:13 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 2,733.5984 | $10.06 | $27,500.00 |
DisclosureSEC source: 0001415889-23-010789 · form4-07052023_090701.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,873.6983 Underlying: Common Stock · 2,733.5984 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $10.06 on June 30, 2023. F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $10.06 on June 30, 2023. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| May 12, 2023 Filed May 16, 2023 17:58 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionOptions- Right to Buy · Derivative | 39,906 | $0.00 Strike: $38.15 | $0.00 |
DisclosureSEC source: 0001062993-23-011182 · form4.xml · derivative · entry 10 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock - Voting · 39,906 shares Expires 2025-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Option exercised; No purchase price required. Read SEC document |
| May 12, 2023 Filed May 16, 2023 17:58 UTC | MCCORMICK & CO INC MKC · Entity 1416 | SaleCommon Stock - Voting | 39,906 | $90.02 | $3,592,378.03 |
DisclosureSEC source: 0001062993-23-011182 · form4.xml · nonDerivative · entry 2 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,579 Read SEC document |
| May 12, 2023 Filed May 16, 2023 17:58 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionCommon Stock - Voting | 39,906 | $38.15 | $1,522,214.37 |
DisclosureSEC source: 0001062993-23-011182 · form4.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,485 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2023 Filed Apr 27, 2023 20:41 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 138.45 | $85.22 | $11,798.71 |
DisclosureSEC source: 0001062993-23-009615 · form4.xml · derivative · entry 8 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Non Qualified Retirement Savings Plan Disclosed balance after: 30,391.189 Underlying: Common Stock - Voting · 138.45 shares Expires not disclosed F1 · derivative.exercise_price: Dividend Reinvestment F1 · derivative.exercise_date: Dividend Reinvestment F1 · derivative.expiration_date: Dividend Reinvestment Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:32 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 2,925.5319 | $9.40 | $27,500.00 |
DisclosureSEC source: 0001415889-23-006023 · form4-04042023_080424.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,140.0999 Underlying: Common Stock · 2,925.5319 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $9.40 on March 31, 2023. F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $9.40 on March 31, 2023. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| March 29, 2023 Filed Mar 31, 2023 17:38 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GrantOptions- Right to Buy · Derivative | 222,223 | $0.00 Strike: $81.79 | $0.00 |
DisclosureSEC source: 0001062993-23-008132 · form4.xml · derivative · entry 9 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,223 Underlying: Common Stock - Voting · 222,223 shares Expires not disclosed F2 · derivative.exercise_date: The option grant becomes exercisable in thirds of each of the first three (3) grant anniversaries. F2 · derivative.expiration_date: The option grant becomes exercisable in thirds of each of the first three (3) grant anniversaries. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 15:29 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionRestricted Stock Units · Derivative | 7,970 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-23-007136 · form4.xml · derivative · entry 10 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock - Voting · 7,970 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units; No purchase price required. F4 · price: The Restricted Stock Units granted on April 1, 2020. F3 · derivative.exercise_date: .The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2021, March 15, 2022 and March 15, 2023. F3 · derivative.expiration_date: .The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2021, March 15, 2022 and March 15, 2023. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 15:29 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Tax withholdingCommon Stock - Voting | 3,663 | $71.78 | $262,930.14 |
DisclosureSEC source: 0001062993-23-007136 · form4.xml · nonDerivative · entry 2 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,579 Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 15:29 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionCommon Stock - Voting | 7,970 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-23-007136 · form4.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units; No purchase price required. Read SEC document |
| March 01, 2023 Filed Jun 8, 2023 13:11 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GiftCommon Stock - Voting | 486 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-013137 · form4.xml · nonDerivative · entry 5 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By 2021 GRAT D Disclosed balance after: 0 F2 · price: Upon termination of the Reporting Person's 2021 grantor retained annuity trusts, 972 shares of Common Stock - Voting were gifted and the remaining 16,290 shares of Common Stock - Voting were transferred to the Reporting Person's direct holdings. No purchase price required. F1 · balance_after: Shares gifted; No purchase price required. Read SEC document |
| March 01, 2023 Filed Jun 8, 2023 13:11 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GiftCommon Stock - Voting | 486 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-013137 · form4.xml · nonDerivative · entry 4 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By 2021 GRAT C Disclosed balance after: 0 F2 · price: Upon termination of the Reporting Person's 2021 grantor retained annuity trusts, 972 shares of Common Stock - Voting were gifted and the remaining 16,290 shares of Common Stock - Voting were transferred to the Reporting Person's direct holdings. No purchase price required. F1 · balance_after: Shares gifted; No purchase price required. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 18:48 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Tax withholdingCommon Stock - Voting | 25,692 | $73.77 | $1,895,383.62 |
DisclosureSEC source: 0001062993-23-003603 · form4.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,272 F1 · shares: Shares withheld for taxes on the shares previously reported on 1/25/2023 for McCormick's Long-Term Incentive Plan. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 18:19 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GrantCommon Stock - Voting | 57,066 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-001361 · form4.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,964 F2 · shares: Shares awarded pursuant to McCormick's Long-Term Incentive Program (LTIP) for the three (3) year performance cycle beginning on December 1, 2019 and ending on November 30, 2022. Read SEC document |
| January 09, 2023 Filed Jan 25, 2023 18:19 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 138.805 | $84.61 | $11,744.29 |
DisclosureSEC source: 0001062993-23-001361 · form4.xml · derivative · entry 10 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Non Qualified Retirement Savings Plan Disclosed balance after: 30,252.739 Underlying: Common Stock - Voting · 138.805 shares Expires not disclosed F1 · derivative.exercise_price: Dividend Reinvestment. F1 · derivative.exercise_date: Dividend Reinvestment. F1 · derivative.expiration_date: Dividend Reinvestment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.